Cardiovascular disease is the No. 1 cause of death in America today and
a couple of Wayne State University scientists may have come up with a
new drug that could knock it down a few notches.
Professors
Catherine Jen, who chairs the nutrition and food science department at
Wayne State, and Joseph Artiss, associate professor of pathology in
Wayne State's medical school, developed
Alpha-Fibe FBCx.
That's
research speak for a dietary fiber so effective it reduces the
absorption of dietary fat and cholesterol, reducing the risk of the
disease. That accordign to a study they recently published in the
highly respected Metabolism Clinical and Experimental journal.
The
product's main feature is the unique ability to bind nine times its own
weight in dietary fat, thus removing 25 to 30 percent of the calories
and 50 to 60 percent of fat from a typical North American diet. The NIH
studies show that Alpha Fibe FBCx is a "smart fiber" that
preferentially binds to saturated and trans fats.
Artiss and
Jen patented the Alpha-Fibe FBCx technology process worldwide. They
plan to commercialize it worldwide with their new company – ArtJen.
Source: Wayne State University
Writer: Jon Zemke
Enjoy this story?
Sign up for free solutions-based reporting in your inbox each week.